Clinical utility of serum fructosamine in long-term monitoring of diabetes mellitus in dogs.

Background: Serum fructosamine (sFA) is used to assess glycaemic control in dogs with diabetes mellitus (DM). Nevertheless, its interpretation is hindered by several limitations.

Methods: This retrospective study evaluates the long-term diagnostic performance of sFA for monitoring clinical control of DM.